MDAI vs. ICU, NMTC, FEMY, IINN, RVP, AKLI, CODX, GBS, TTOO, and PYPD
Should you be buying Spectral AI stock or one of its competitors? The main competitors of Spectral AI include SeaStar Medical (ICU), NeuroOne Medical Technologies (NMTC), Femasys (FEMY), Inspira Technologies Oxy B.H.N. (IINN), Retractable Technologies (RVP), Akili (AKLI), Co-Diagnostics (CODX), GBS (GBS), T2 Biosystems (TTOO), and PolyPid (PYPD). These companies are all part of the "surgical & medical instruments" industry.
SeaStar Medical (NASDAQ:ICU) and Spectral AI (NASDAQ:MDAI) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment, community ranking and earnings.
Spectral AI has a consensus price target of $4.00, suggesting a potential upside of 128.57%. Given SeaStar Medical's higher probable upside, analysts plainly believe Spectral AI is more favorable than SeaStar Medical.
SeaStar Medical and Spectral AI both received 1 outperform votes by MarketBeat users.
SeaStar Medical has a beta of -0.96, suggesting that its share price is 196% less volatile than the S&P 500. Comparatively, Spectral AI has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500.
In the previous week, SeaStar Medical had 2 more articles in the media than Spectral AI. MarketBeat recorded 7 mentions for SeaStar Medical and 5 mentions for Spectral AI. Spectral AI's average media sentiment score of 0.67 beat SeaStar Medical's score of 0.55 indicating that SeaStar Medical is being referred to more favorably in the media.
1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 67.1% of Spectral AI shares are held by institutional investors. 3.0% of SeaStar Medical shares are held by insiders. Comparatively, 56.7% of Spectral AI shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Spectral AI has higher revenue and earnings than SeaStar Medical.
Summary
Spectral AI beats SeaStar Medical on 8 of the 10 factors compared between the two stocks.
Get Spectral AI News Delivered to You Automatically
Sign up to receive the latest news and ratings for MDAI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MDAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Spectral AI Competitors List
Related Companies and Tools
